SPL026 Small Pharma (DMT.V) is a London-based psychedelics company focusing on DMT-assisted psychotherapy for depression, and they’re already doing Phase 1 clinical trials, with Phase 2 on the…
Taylor Gavinchuk
PTSD is fascinating in that two people can have identical experiences, one can largely forget the experience while the other is in for a lifetime of suffering. What…
“The cardinal rule is to keep them playing and to keep them coming back. The longer they play, the more they lose, and in the end, we get it…
Speed Before the widespread fear-mongering in Western media and culture around LSD it was becoming rather popular in the psychiatry community in both North America and Europe. In the…
Early money Earlier this week California introduced a bill to decriminalize psychedelics. If passed, SB 519 will approve the use of mushrooms, MDMA, LSD, mescaline, and ibogaine for…
Boomers Element Nutritional Sciences (ELMT.C) has a very specific objective in mind – plant-based foods for boomers. There a ton of new CPG health companies out there, most…
Anyone else watching charts trend downwards? Yeah. There’s a reason that junior market traders hold tight to the saying of “May: sell and go away”, but ‘May’ started unusually…
A different approach to MDD I’m big on companies having a unique approach to whatever they are doing. Many psychedelics companies are targetting depression but from a psychedelic-assisted therapy…
‘Growth hacking’ Early on in the shroom boom critics had one major pain point – legalization is too far away. I remember the stiffs at the Cannacord conference a…
Multiple pivots Mind Cure (MCUR.C) began as a mushroom nootropic deal that has since shifted to ibogaine production and the development digital platforms. The company has been able to…